Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
ODT
Odyssey Therapeutics
ODTX
Price / sales
Price / sales at other companies
AutoZone
AZO
2.4×
-0.9×
Synopsys
SNPS
10.7×
-0.3×
Northern Trust
NTRS
2.5×
-0.9×
Dycom Industries
DY
2×
+1.0×
Nucor
NUE
1.1×
+0.2×
Berkshire Hathaway
BRK.A
2.8×
-0.3×
Other financials
Income statement
See full
Revenue
-
-100%
Operating income
-$55.5M
-32.3%
Net income
-$52.8M
-28.0%
EPS (diluted)
-$1.74
+94.1%
Balance sheet
See full
Cash & equivalents
$82.0M
-49.7%
Total debt
$24.8M
+8,175%
Total equity
$421.2M
+197%
Total assets
$483.9M
—
Cash flow
See full
Operating cash flow
-$34.5M
-0.7%
CapEx
$186.0K
+541%
Free cash flow
-$34.7M
-1.2%
Valuation
See full
Market cap
$1B
+27.8%
Enterprise value
$946.17M
—
Profitability
See full
Operating margin
-6,129%
—
Net margin
-5,934%
—
FCF margin
-5,203.9%
—
Returns & leverage
See full
Return on equity
-8,434.8%
—
Debt / equity
0.1×
—
Current ratio
11.4×
—
Watchlist
Screener
Filings
Earnings
Charts